[ Price : $8.95]
FDA accepts for review an Allergan Aesthetics supplemental BLA for Botox Cosmetic (onabotulinumtoxinA) for the temporary improveme...[ Price : $8.95]
FDA issues an early alert warning healthcare providers not to use certain Becton Dickinson intraosseous vascular access needle set...[ Price : $8.95]
Liebel-Flarsheim recalls one lot of its Optiray Imaging Bulk Package 350 radiographic contrast agent after identifying particulate...[ Price : $8.95]
The International Council for Harmonization says its electronic common technical document working group has issued updated support...[ Price : $8.95]
Arrowhead Pharmaceuticals agrees to acquire an FDA Rare Pediatric Disease Priority Review Voucher from an undisclosed third party ...[ Price : $8.95]
Four stakeholders praise an FDA draft guidance on streamlining some oncology nonclinical safety studies and recommend improvements...[ Price : $8.95]
FDA undertakes a broad modernization of its inspection program, including expanded use of risk-based oversight, greater reliance o...[ Price : $8.95]
FDA issues an updated final guidance entitled Applying Human Factors and Usability Engineering to Medical Devices.